Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Mier

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Cell Adhesion and Communication|November 1, 1996
L-selectin crosslinking induces integrin-dependent adhesion: evidence for a signaling pathway involving PTK but not PKCM A Sikorski, D E Staunton, J W Mier
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1988
IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cellsR P Numerof, F R Aronson, J W Mier
Journal of Supramolecular Structure|January 1, 1980
Human T-cell growth factor: parameters for productionF W Ruscetti, J W Mier, R C Gallo
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Clinical use of systemic IL-12 therapyJ A Gollob, J W Mier, M B Atkins
The New England Journal of Medicine|April 5, 1990
An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapyM S Klempner, R Noring, J W Mier, et al.
International Journal of Immunopharmacology|January 1, 1983
The effect of differentiation inducers on the sensitivity of two myeloid cell lines to natural killer (NK) cell-mediated lysisM Golden, R A Dempsey, J W Mier, et al.
Cytokine|October 1, 1995
Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapyH Tilg, M B Atkins, C A Dinarello, et al.
Transfusion|July 1, 1989
Lymphokine-activated killer cell generation and recovery. Comparison of an automated cell processing device and a manual procedureT Ryan, M B Atkins, J W Mier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12J A Gollob, K G Veenstra, J W Mier, et al.
The American Journal of Medicine|April 1, 1992
Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case reportN P Sauter, M B Atkins, J W Mier, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Cell Adhesion and Communication|November 1, 1996
L-selectin crosslinking induces integrin-dependent adhesion: evidence for a signaling pathway involving PTK but not PKCM A Sikorski, D E Staunton, J W Mier
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1988
IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cellsR P Numerof, F R Aronson, J W Mier
Journal of Supramolecular Structure|January 1, 1980
Human T-cell growth factor: parameters for productionF W Ruscetti, J W Mier, R C Gallo
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Clinical use of systemic IL-12 therapyJ A Gollob, J W Mier, M B Atkins
The New England Journal of Medicine|April 5, 1990
An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapyM S Klempner, R Noring, J W Mier, et al.
International Journal of Immunopharmacology|January 1, 1983
The effect of differentiation inducers on the sensitivity of two myeloid cell lines to natural killer (NK) cell-mediated lysisM Golden, R A Dempsey, J W Mier, et al.
Cytokine|October 1, 1995
Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapyH Tilg, M B Atkins, C A Dinarello, et al.
Transfusion|July 1, 1989
Lymphokine-activated killer cell generation and recovery. Comparison of an automated cell processing device and a manual procedureT Ryan, M B Atkins, J W Mier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12J A Gollob, K G Veenstra, J W Mier, et al.
The American Journal of Medicine|April 1, 1992
Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case reportN P Sauter, M B Atkins, J W Mier, et al.
Pageof 9